Dean M Wingerchuk MD
Neuroimmunology/Multiple Sclerosis
"Professor of Neurology at Mayo Clinic, and Chair of the Mayo Clinic Division of Multiple Sclerosis (MS) and Autoimmune Neurology in Scottsdale Mayo Medical School"
Join to View Full Profile
13400 E Shea BlvdScottsdale, AZ 85259
Phone+1 480-301-8000
Dr. Wingerchuk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1994 - 1997- Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 1993 - 1994
University Saskatchewan Royal HospitalClass of 1993
Certifications & Licensure
NH State Medical License 2015 - Present
AZ State Medical License 1997 - 2026
MN State Medical License 1994 - 2025
NV State Medical License 2015 - 2017
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) Start of enrollment: 2007 Mar 01
- Maintenance Plasma Exchange for Neuromyelitis Optica Start of enrollment: 2012 Jun 01
Publications & Presentations
PubMed
- Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder.Alessandro Dinoto, Laura Cacciaguerra, Karl N Krecke, John Jing-Wei Chen, Dean M Wingerchuk
Neurology(R) Neuroimmunology & Neuroinflammation. 2025-01-01 - 3 citationsSafety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.Bruce A C Cree, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, Dean M Wingerchuk
The Lancet. Neurology. 2024-06-01 - 1 citationsMRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Yes.Edgar Carnero Contentti, Dean M Wingerchuk
Multiple Sclerosis. 2024-01-01
Press Mentions
Careful Evaluation, Genetic Testing Offer a New Path ForwardFebruary 10th, 2020
Estudo Mostra Que Droga Reduz Risco De Recaída Da Neuromielite ÓpticaMay 16th, 2019
Drug Reduces Risk of Relapse with Neuromyelitis OpticaMay 6th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
